Clinical Trial Update: Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a conditioning regimen of busulfan, etoposide, and total-body irradiation for patients undergoing donor stem cell or bone marrow transp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• BUSULFAN (Busulfan)
• Etoposide (Etoposide)
• Total Body Irradiation

Snippet

Sponsor: City of Hope Medical Center | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-10-10